By :- Team VOH
7 Jun 2024
Dr. Srikanth Dikkala, Consultant Medical Oncologist, HCG Cancer Centre, Visakhapatnam
Traditional cancer treatments such as surgery, radiation, and chemotherapy, while effective, often lead to severe side effects that can drastically impact a patient's quality of life. Fortunately, a new era of treatment is emerging, driven by precision medicine. This innovative approach tailors’ treatments to the unique characteristics of an individual's cancer, offering a more personalized and effective path to recovery. One of the key components of precision medicine is targeted therapy, which has become a powerful weapon in the battle against bladder cancer. It promises effective treatment with fewer side effects, providing hope for patients seeking a better quality of life during their fight against cancer.
Targeted Therapy: A Sniper Approach to Cancer Cells
In contrast to traditional chemotherapy's broad and often scattered approach, which can damage healthy cells alongside cancerous ones, targeted therapy operates like a sniper, precisely targeting specific molecules essential for cancer cell growth. This precision reduces side effects like nausea, hair loss, and fatigue, thereby enhancing a patient's quality of life while still delivering an effective and focused attack on cancer.
Biomarkers: The Key to Unlocking Personalized Treatment
The effectiveness of targeted therapy hinges on identifying the unique molecular makeup of a patient's tumor. This is achieved through biomarker testing, a process where tumor samples are analyzed for specific genetic alterations. These biomarkers act as fingerprints, guiding physicians towards the targeted therapies most likely to benefit the individual patient.
Examples of Targeted Therapies in Bladder Cancer
Research has yielded promising possibilities for targeted therapy in bladder cancer. Drugs like FGFR inhibitors target abnormal proteins that fuel cancer cell growth, essentially starving the tumor. Additionally, Antibody-Drug Conjugates (ADCs) function like guided smart bombs, with monoclonal antibodies locating cancer cells and delivering a powerful chemotherapy dose directly to the target, reducing damage to healthy tissue. Enfortumab vedotin (Padcev) and Sacituzumab govitecan (Trodelvy) are examples of ADCs gaining significant attentionin the treatment of bladder cancer.
The Future of Targeted Therapy in Bladder Cancer
The future of bladder cancer treatment is bright thanks to the ongoing exploration of targeted therapies. As research unlocks the intricate molecular makeup of bladder cancer, even more precise and effective drugs are on the horizon. This progress is paving the way for a future where treatments are tailored to individual patients, leading to more successful outcomes and fewer side effects.
Personalized treatment plans, designed to address the specific characteristics of each patient's cancer, promise to boost survival rates and ease the treatment burden. This approach can significantly improve patients' quality of life, offering hope and optimism for those battling this challenging disease.
27 Jul 2024
27 Jul 2024
27 Jul 2024
26 Jul 2024
26 Jul 2024